INFI - Infinity Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

INFI - Infinity Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE 3.40%
PRICE $2.13





Request Prediction

Infinity Pharmaceuticals Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Buy candidate since 2018-08-30
Shorts 3.61% ( 2018-08-31 )
Cash 55.6 mill
Loans n/a
Beta 2.32
ROA -42.75

Infinity Pharmaceuticals gained 3.40% in the last trading day, rising from $2.06 to $2.13 The price has fallen in 6 of the last 10 days and is down by -6.17% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 167 466 more shares were traded than the day before. In total, 281 549 shares bought and sold for approximately $599 699.00.


Infinity Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.58% during the next 3 months and, with 90% probability hold a price between $2.21 and $2.92 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Infinity Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $2.15. On a fall, the stock will find some support from the long-term average at approximately $2.06. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. Infinity Pharmaceuticals has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 54 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Infinity Pharmaceuticals finds support from accumulated volume at $2.05.

Support: $2.05 Price: $2.13 Resistance: $2.26


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 5.91%. For the last week, the stock has had a daily average volatility of 5.04%.

Our recommended stoploss: $2.01 (-5.50%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Infinity Pharmaceuticals holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.

Strong Buy Candidate

Click for Top 5 Strong Buy Candidates
INFI $2.13 $0.07(3.40%)
INFI is up $0.07 today, but where's it headed in October?
Zacks Investment Research is releasing its prediction for INFI based on the 1-3 month system that more than doubles the S&P 500.

Click here – the INFI analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with